Biochem Soc Trans. 2021 Apr 30;49(2):551-562. doi: 10.1042/BST20190236.
Parkinson's disease and mitophagy: an emerging role for LRRK2.
Biochemical Society transactions
Francois Singh, Ian G Ganley
Affiliations
Affiliations
- MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee DD1 5EH, U.K.
PMID: 33769432
PMCID: PMC8106497 DOI: 10.1042/BST20190236
Abstract
Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects around 2% of individuals over 60 years old. It is characterised by the loss of dopaminergic neurons in the substantia nigra pars compacta of the midbrain, which is thought to account for the major clinical symptoms such as tremor, slowness of movement and muscle stiffness. Its aetiology is poorly understood as the physiological and molecular mechanisms leading to this neuronal loss are currently unclear. However, mitochondrial and lysosomal dysfunction seem to play a central role in this disease. In recent years, defective mitochondrial elimination through autophagy, termed mitophagy, has emerged as a potential contributing factor to disease pathology. PINK1 and Parkin, two proteins mutated in familial PD, were found to eliminate mitochondria under distinct mitochondrial depolarisation-induced stress. However, PINK1 and Parkin are not essential for all types of mitophagy and such pathways occur in most cell types and tissues in vivo, even in the absence of overt mitochondrial stress - so-called basal mitophagy. The most common mutation in PD, that of glycine at position 2019 to serine in the protein kinase LRRK2, results in increased activity and this was recently shown to disrupt basal mitophagy in vivo. Thus, different modalities of mitophagy are affected by distinct proteins implicated in PD, suggesting impaired mitophagy may be a common denominator for the disease. In this short review, we discuss the current knowledge about the link between PD pathogenic mutations and mitophagy, with a particular focus on LRRK2.
© 2021 The Author(s).
Keywords: Parkinsons disease; autophagy; leucine-rich repeat kinase; mitophagy
References
- Neurobiol Dis. 2020 Nov;145:105056 - PubMed
- Neurosci Lett. 2019 Jul 13;705:7-13 - PubMed
- Hum Mol Genet. 2019 Aug 15;28(16):2696-2710 - PubMed
- Am J Hum Genet. 2016 Mar 3;98(3):500-513 - PubMed
- EMBO J. 2017 Jun 14;36(12):1688-1706 - PubMed
- EMBO J. 2014 Feb 18;33(4):282-95 - PubMed
- Front Neurol. 2017 Oct 04;8:527 - PubMed
- Nat Commun. 2017 Mar 09;8:14697 - PubMed
- J Cell Biol. 2010 Apr 19;189(2):211-21 - PubMed
- Biochem Soc Trans. 2012 Oct;40(5):1134-9 - PubMed
- Oxid Med Cell Longev. 2013;2013:683920 - PubMed
- Hum Mol Genet. 2012 Feb 15;21(4):890-9 - PubMed
- iScience. 2020 Dec 31;24(1):102029 - PubMed
- Autophagy. 2010 Oct;6(7):871-8 - PubMed
- Adv Exp Med Biol. 2017;1037:89-95 - PubMed
- Cell Metab. 2018 Feb 6;27(2):439-449.e5 - PubMed
- PLoS One. 2010 Feb 23;5(2):e9367 - PubMed
- Nature. 2014 Jun 5;510(7503):162-6 - PubMed
- Open Biol. 2018 Nov 7;8(11): - PubMed
- Cell Stress. 2020 Mar 04;4(5):99-113 - PubMed
- J Neuropsychiatry Clin Neurosci. 2002 Spring;14(2):223-36; discussion 222 - PubMed
- J Cell Biol. 2016 Aug 1;214(3):333-45 - PubMed
- Mov Disord. 2021 Mar;36(3):704-715 - PubMed
- Science. 2013 Apr 19;340(6130):350-3 - PubMed
- Autophagy. 2019 Jul;15(7):1296-1308 - PubMed
- Hum Mol Genet. 2011 Jan 1;20(1):40-50 - PubMed
- J Neurochem. 2016 Oct;139 Suppl 1:77-90 - PubMed
- Acta Neuropathol. 2018 Oct;136(4):607-620 - PubMed
- Acta Neuropathol Commun. 2019 Mar 14;7(1):41 - PubMed
- Sci Rep. 2017 Oct 9;7(1):12816 - PubMed
- Neurobiol Dis. 2018 Jan;109(Pt B):249-257 - PubMed
- BMC Neurol. 2008 Mar 28;8:6 - PubMed
- J Inherit Metab Dis. 2010 Apr;33(2):167-73 - PubMed
- J Cell Biol. 2018 Oct 1;217(10):3625-3639 - PubMed
- EMBO J. 2018 Jun 15;37(12): - PubMed
- Mol Neurodegener. 2019 Aug 29;14(1):36 - PubMed
- Nat Neurosci. 2013 Sep;16(9):1257-65 - PubMed
- Elife. 2016 Jan 29;5: - PubMed
- Trends Biochem Sci. 2015 Apr;40(4):200-10 - PubMed
- Neurobiol Dis. 2018 Mar;111:26-35 - PubMed
- Nat Commun. 2019 Dec 5;10(1):5570 - PubMed
- Hum Mol Genet. 2011 Mar 1;20(5):867-79 - PubMed
- Neurology. 2010 Nov 30;75(22):2017-20 - PubMed
- J Mol Biol. 2020 Jan 3;432(1):206-230 - PubMed
- Autophagy. 2019 Jul;15(7):1182-1198 - PubMed
- Nat Rev Neurol. 2020 Feb;16(2):97-107 - PubMed
- Mol Neurodegener. 2017 Sep 29;12(1):70 - PubMed
- Neurobiol Dis. 2016 Jun;90:43-50 - PubMed
- J Cell Biol. 2008 Dec 1;183(5):795-803 - PubMed
- Nat Cell Biol. 2010 Feb;12(2):119-31 - PubMed
- Biochim Biophys Acta. 2010 Mar;1800(3):223-34 - PubMed
- Neurobiol Dis. 2014 Feb;62:381-6 - PubMed
- FEBS J. 2018 Apr;285(7):1185-1202 - PubMed
- Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6400-5 - PubMed
- Front Neurosci. 2020 May 25;14:498 - PubMed
- Sci Rep. 2012;2:1002 - PubMed
- Science. 2015 Dec 4;350(6265):aad2459 - PubMed
- Cell Stem Cell. 2016 Dec 1;19(6):709-724 - PubMed
- Biochem J. 2018 Jun 6;475(11):1861-1883 - PubMed
- Cell. 2016 Jul 14;166(2):314-327 - PubMed
- Dis Model Mech. 2017 Sep 1;10(9):1075-1087 - PubMed
- J Cell Biol. 2005 Nov 21;171(4):603-14 - PubMed
- Neurobiol Dis. 2013 Mar;51:35-42 - PubMed
- PLoS Biol. 2010 Jan 26;8(1):e1000298 - PubMed
- Mol Cell. 2014 Nov 6;56(3):360-75 - PubMed
- Biochem Soc Trans. 2018 Dec 17;46(6):1707-1712 - PubMed
- Cell Metab. 2013 Jun 4;17(6):941-953 - PubMed
- Hum Mol Genet. 2019 May 15;28(10):1645-1660 - PubMed
- J Parkinsons Dis. 2017;7(s1):S11-S19 - PubMed
- J Neurosci. 2012 Mar 21;32(12):4240-6 - PubMed
- Annu Rev Cell Dev Biol. 2020 Oct 6;36:237-264 - PubMed
- Nature. 2020 Dec;588(7837):344-349 - PubMed
- Mov Disord. 2020 Jul;35(7):1245-1248 - PubMed
- J Biol Chem. 2018 Mar 23;293(12):4566-4574 - PubMed
- Nat Genet. 2017 Oct;49(10):1511-1516 - PubMed
- Science. 1983 Feb 25;219(4587):979-80 - PubMed
- Nat Genet. 2014 Sep;46(9):989-93 - PubMed
- Genes Cells. 2016 Jul;21(7):772-88 - PubMed
- Biochem J. 2014 May 15;460(1):127-39 - PubMed
- J Cell Biol. 2018 May 7;217(5):1613-1622 - PubMed
- Autophagy. 2020 Feb;16(2):203-222 - PubMed
- Neurosci Res. 2020 Oct;159:34-39 - PubMed
- Hum Mol Genet. 2018 Sep 15;27(18):3189-3205 - PubMed
- Biochem Soc Trans. 2020 Oct 30;48(5):2185-2194 - PubMed
- J Cell Biol. 2016 Aug 1;214(3):275-91 - PubMed
- J Neurochem. 2016 Oct;139 Suppl 1:216-231 - PubMed
- Biochem J. 2016 Oct 15;473(20):3563-3580 - PubMed
- Science. 2018 Apr 6;360(6384):36-37 - PubMed
- Hum Mol Genet. 2019 Oct 1;28(19):3232-3243 - PubMed
- Mol Biol Cell. 2017 Mar 15;28(6):712-715 - PubMed
- Sci Adv. 2020 Nov 11;6(46): - PubMed
- Biochem J. 2018 Apr 9;475(7):1271-1293 - PubMed
- Cell Tissue Res. 2018 Jul;373(1):79-90 - PubMed
- Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):2389-2394 - PubMed
- EMBO Rep. 2013 May;14(5):450-7 - PubMed
- Front Cell Dev Biol. 2019 Jun 20;7:113 - PubMed
- Front Neurol. 2020 Aug 25;11:881 - PubMed
- Curr Neurol Neurosci Rep. 2018 Apr 3;18(5):21 - PubMed
- Essays Biochem. 2017 Dec 12;61(6):609-624 - PubMed
- Sci Rep. 2017 Aug 31;7(1):10300 - PubMed
- Nat Commun. 2019 Mar 1;10(1):994 - PubMed
- Nature. 2015 Aug 20;524(7565):309-314 - PubMed
- J Neural Transm (Vienna). 2013 Apr;120(4):509-16 - PubMed
- Elife. 2018 Nov 06;7: - PubMed
- Cells. 2019 Jul 12;8(7): - PubMed
- Neurobiol Dis. 2015 Jun;78:172-95 - PubMed
- Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):378-83 - PubMed
- EMBO Rep. 2012 Apr;13(4):378-85 - PubMed
- Nature. 2019 Jul;571(7766):565-569 - PubMed
- J Appl Physiol (1985). 2010 Jun;108(6):1745-56 - PubMed
- Mech Ageing Dev. 2020 Jan;185:111196 - PubMed
- Nat Commun. 2018 Feb 26;9(1):817 - PubMed
- J Biol Chem. 2014 May 16;289(20):13986-95 - PubMed
- EMBO Rep. 2015 Jun;16(6):709-18 - PubMed
- Autophagy. 2013 Nov 1;9(11):1758-69 - PubMed
- Sci Transl Med. 2016 Jun 8;8(342):342ra78 - PubMed
Publication Types
Grant support